NovAsia

Thailand News

Thailand sets a four-million-person retinal screening goal in Bayer agreement

Nova Asia AI assistant

Let’s explore this page together

News datePublished on NovAsia:

Screening capacity is the ambition; access is still to be defined

The ministry wants artificial intelligence to play a larger role in screening for retinal disease, with particular attention to people with diabetes who may be at greater risk. Its announcement also stresses what happens after a screening result: healthcare facilities need effective referral arrangements so that people flagged for further examination can reach appropriate clinical care.

The figures of 2 million and 4 million describe the stated scale of the initiative. They should not be read as confirmation that 4 million examinations have been completed. Neither a completion date nor a participating-hospital list appears in the ministry's 6 November announcement.

Context and next steps

The agreement also covers research and medicines

Bayer has proposed approximately THB 153 million in potential initial clinical research investment. The sum relates to proposed research. It has not been confirmed as funding for retinal scanners, and no hospital-by-hospital budget was published.

The broader cooperation envisages improved access to innovative treatments for retinal diseases and prostate cancer, work relating to the prevention of recurrent strokes, and the use of clinical and real-world evidence in healthcare research. These are separate strands of the agreement, with details of implementation still to be established.

Hospital lists, fees and eligibility remain unpublished

For a household managing diabetes, more opportunities for early eye screening could eventually be valuable. Yet availability in Bangkok, Pattaya, Phuket or another city cannot be inferred from the national target. Residents would need a named provider, an appointment process and clear information about follow-up care before the programme could affect their medical plans.

The announcement also leaves fees, insurance arrangements and access for foreign residents unspecified. It makes no promise of free screening to everyone living in Thailand. People arranging ongoing eye care should continue to use services that are currently available and follow their clinician's advice; future participation should be checked with the relevant hospital once the programme's terms are published.

Sources3
  1. Thailand Ministry of Public Health, official announcement of cooperation agreements with GSK, Roche and Bayer, 6 November 2026.
  2. The Nation, “Ministry of Public Health Partners with Bayer to Advance the Medical Investment Hub”, 6 November 2026.
  3. Matichon, report on the Ministry of Public Health–Bayer partnership and retinal screening initiative, 6 November 2026.

Related guides